Skip to content

Bio-Rad Laboratories, Inc. BIO.B Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent

Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent at other companies

Allegion logo
AllegionALLE
$450K+164%
Jones Lang LaSalle logo
Jones Lang LaSalleJLL
$0-100%
Armstrong World Industries logo
Armstrong World IndustriesAWI
-$600K0.0%
Albertsons Companies logo
Albertsons CompaniesACI
$500K-37.5%
Rayonier logo
RayonierRYN
$1K-50.0%
Royal Caribbean Group logo
Royal Caribbean GroupRCL
$2M-50.0%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent?
Bio-Rad Laboratories, Inc. (BIO.B) reported other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent of $500K in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent changed year-over-year?
Bio-Rad Laboratories, Inc.'s other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent increased by 150.0% year-over-year, from $200K to $500K.